|Assessment Status||Rapid review complete|
|Indication||For the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.|
|Rapid review commissioned||23/07/2019|
|Rapid review completed||15/08/2019|
|Rapid review outcome||A full HTA is not recommended. The NCPE recommends that doxylamine/pyridoxine (Xonvea®) not be considered for reimbursement at the submitted price*|
* This recommendation should be considered while also having regard to the criteria
specified in the Health (Pricing and Supply of Medial Goods) Act 2013.